Association of High Homocysteine Levels With the Risk Stratification in Hypertensive Patients at Risk of Stroke

被引:27
作者
Pang, Hui [1 ]
Han, Bing [1 ]
Fu, Qiang [1 ]
Zong, Zhenkun [2 ]
机构
[1] Southeast Univ, Coll Med, Affiliated XuZhou Hosp,Dept Cardiovasc Med, XuZhou Cent Hosp,Xuzhou Clin Sch,Xuzhou Med Coll, 199 Jiefang Rd, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China
关键词
homocysteine; hypertension; risk factors; stratification; stroke; DIABETES-MELLITUS; ISCHEMIC-STROKE; BLOOD-PRESSURE; HEART; GLUCOSE; DISEASE; MORTALITY;
D O I
10.1016/j.clinthera.2016.03.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: We aimed to investigate the association between stroke morbidity and different stratifications of classic risk factors, such as increasing age, body mass index (BMI), blood lipids, and blood glucose, in hypertensive patients with high homocysteine levels. Methods: A cross-sectional study of 2258 patients with primary hypertension were enrolled in this study, including 871 stroke cases (62.89%) in 1385 hypertensive patients without hyperhomocysteinemia (HHcy) and 647 (74.11%) stroke cases in 873 hypertensive patients with HHcy. Basic information of patients were collected, including age, sex, height, weight, smoking, alcohol consumption, and disease history. Blood chemical assays were performed to determine the levels of glucose, triglycerides, high density lipoprotein cholesterol (HDL-C), total cholesterol, and homocysteine. Subsequently, comparison of stroke morbidity between the 2 groups was performed after the stratification of risk factors. Moreover, the correlation between the stroke morbidity and the risk factors was analyzed using a trend test in patients with H-type hypertension. Univariate and multivariate logistic regression analyses were used to evaluate the association between baseline factors and prevalence of stroke in H-type hypertensive patients. Findings: After the stratification of risk factors, a statistical difference was noted in age (range, 45-74 yrs), glucose ranges (<6.1 and >= 7.0 mmol/L), BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), non-HDL-C, and triglyceride level of <200 mg/dL (P<0.05) in the H-type hypertension group compared with those in non H-type hypertension group. Gradual elevation of stroke morbidity was identified with the increase of fasting glucose, SBP, and DBP. In multivariate logistic regression analysis, only higher SBP, DBP, fasting glucose level, homocysteine, and history of diabetes mellitus were the independent predictors for the stroke morbidity. Implications: Comprehensive evaluation and strict management of multiple risk factors have become increasingly important in the alleviation of stroke morbidity for H-type hypertensive patients because these patients were more sensitive to the classic risk factors. (C) 2016 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:1184 / 1192
页数:9
相关论文
共 26 条
[1]  
Banecka-Majkutewicz Z, 2012, ACTA BIOCHIM POL, V59, P495
[2]   The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe -: The Euro Heart Survey on diabetes and the heart [J].
Bartnik, M ;
Rydén, L ;
Ferrari, R ;
Malmberg, K ;
Pyörälä, K ;
Simoons, M ;
Standl, E ;
Soler-Soler, J ;
Öhrvik, J .
EUROPEAN HEART JOURNAL, 2004, 25 (21) :1880-1890
[3]   Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties [J].
Cacciapuoti, Federico .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (01) :82-88
[4]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241
[5]   Launch of the health-care reform plan in China [J].
Chen, Zhu .
LANCET, 2009, 373 (9672) :1322-1324
[6]   Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29 [J].
Davis, TME ;
Millns, H ;
Stratton, IM ;
Holman, RR ;
Turner, RC .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1097-1103
[7]   Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis [J].
Emdin, Connor A. ;
Rahimi, Kazem ;
Neal, Bruce ;
Callender, Thomas ;
Perkovic, Vlado ;
Patel, Anushka .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (06) :603-615
[8]   Homocysteine and metabolic syndrome: From clustering to additional utility in prediction of coronary heart disease [J].
Esteghamati, Alireza ;
Hafezi-Nejad, Nima ;
Zandieh, Ali ;
Sheikhbahaei, Sara ;
Ebadi, Maryam ;
Nakhjavani, Manouchehr .
JOURNAL OF CARDIOLOGY, 2014, 64 (3-4) :290-296
[9]   The cost of cerebral ischaemia [J].
Flynn, R. W. V. ;
MaWalter, R. S. M. ;
Doney, A. S. F. .
NEUROPHARMACOLOGY, 2008, 55 (03) :250-256
[10]  
Gariglio Luis, 2014, Arch. Cardiol. Méx., V84, P71